GRM5 and Parkinson disease: [18F]FPEB has demonstrated deficits in the striatal and neocortical mGluR5s in people with mild Huntington’s disease [34,35] and increments in the mGluR5s in people with mild Parkinson’s disease [36,37,38] and men with ASD [25].